Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 known ✓ | Q13547 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | LMNA | P02545 | 5/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | NPC1 | O15118 | 2/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | GSK3B | P49841 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 5/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | CTNNB1 | P35222 | 4/20 | 0.54 |
| ▸ | WNT3A | P56704 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL170394 | 0.98 | ALDH1A1 (0.69) | ALDH1A1LMNAMEN1KMT2ANPC1 | |
| SCHEMBL4132169 | 0.92 | ALDH1A1 (0.61) | ALDH1A1LMNAMEN1KMT2ANPC1 | |
| SCHEMBL4120551 | 0.82 | ALDH1A1 (0.53) | ALDH1A1LMNAMEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL15974201 | 0.82 | ALDH1A1 (0.60) | ALDH1A1LMNAMEN1KMT2ANPC1 | |
| SCHEMBL16419608 | 0.81 | ALDH1A1 (0.65) | ALDH1A1LMNAMEN1KMT2ANPC1 | |
| SCHEMBL14152319 | 0.81 | CTNNB1 (0.53) | ALDH1A1LMNAMEN1KMT2ANPC1 | |
| SCHEMBL2216212 | 0.81 | ALDH1A1 (1.00) | ALDH1A1LMNAMEN1KMT2ANPC1 | |
| SCHEMBL15974627 | 0.80 | ALDH1A1 (0.62) | ALDH1A1LMNAMEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL994292 | 0.80 | ALDH1A1 (0.57) | ALDH1A1LMNAMEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL691269 | 0.80 | LMNA (0.57) | ALDH1A1LMNAMEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118084859-B | Preparation method of 3-methylamino-1- (2-thienyl) -1-propanone hydrochloride | 杭州知峪生物科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118497160-A | Ketone reductase mutant and application thereof | 杭州善泰生物科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118084859-A | Preparation method of 3-methylamino-1- (2-thienyl) -1-propanone hydrochloride | 杭州知峪生物科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-116640115-A | Preparation method of 3-methylamino-1- (2-thienyl) -1-propanone hydrochloride | 浙江工业大学 | 2023-08-25 | — | — | CN | claimed |
| CN-111793056-A | Preparation method of duloxetine intermediate | 广州康瑞泰药业有限公司 | 2020-10-20 | — | — | CN | claimed |
| CN-109134427-B | Synthetic method of 3-methylamino-1- (2-thienyl) -1-acetone hydrochloride | 浙江乐普药业股份有限公司 | 2020-06-30 | — | — | CN | claimed |
| CN-109134427-A | A kind of synthetic method of 3- methylamino -1- (2- thienyl) -1- propanone hydrochloride | 浙江乐普药业股份有限公司 | 2019-01-04 | — | — | CN | claimed |
| JP-4837552-B2 | — | — | 2011-12-14 | — | — | JP | claimed |
| US-20060128791-A1 | 3-Methylamino-1-(2-thienyl)-1-propanone, production and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-15 | — | — | US | claimed |
| EP-1587802-A1 | 3-METHYLAMINO-1-(2-THIENYL)-1-PROPANONE, PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-26 | — | — | EP | claimed |
| WO-2004065376-A1 | 3-METHYLAMINO-1-(2-THIENYL)-1-PROPANONE, PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-05 | — | — | WO | claimed |
| CN-118084859-B | Preparation method of 3-methylamino-1- (2-thienyl) -1-propanone hydrochloride | 杭州知峪生物科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118084859-B | Preparation method of 3-methylamino-1- (2-thienyl) -1-propanone hydrochloride | 杭州知峪生物科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118084859-B | Preparation method of 3-methylamino-1- (2-thienyl) -1-propanone hydrochloride | 杭州知峪生物科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118497160-A | Ketone reductase mutant and application thereof | 杭州善泰生物科技有限公司 | 2024-08-16 | — | — | CN | disclosed |
| WO-2005080370-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE 1-SUBSTITUTED-3-AMINOALCOHOLS | LONZA AG (CH) | 2005-09-01 | — | — | WO | disclosed |
| EP-1566383-A1 | Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols | Lonza AG (CH) | 2005-08-24 | — | — | EP | disclosed |
| EP-1510517-A1 | Process for the asymmetric hydrogenation of beta-amino ketones | Lonza AG (CH) | 2005-03-02 | — | — | EP | disclosed |
| WO-2004031168-A2 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF OPTICALLY ACTIVE 3-AMINO-1-(2-THIENYL)-1-PROPANOL DERIVATIVES | LONZA AG (CH) | 2004-04-15 | — | — | WO | disclosed |
| WO-2004005307-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 3-N-METHYLAMINO-1-(2-THIENYL)-1-PROPANOL | LONZA AG (CH) | 2004-01-15 | — | — | WO | disclosed |